期刊文献+

水蛭地龙提取液治疗急性脑梗死的作用机制及疗效 被引量:23

The efficacy and mechnisam of extract liquor from hirudo and earthworm for patients with acute cerebral infarction
下载PDF
导出
摘要 目的探讨水蛭地龙提取液(extractliquorfromhirudoandearthworm,ELHE)治疗急性脑梗死的作用机制及疗效。方法78例急性脑梗死患者被随机分为2组:对照组38例,进行基础治疗;治疗组40例,在基础治疗的同时静脉给予ELHE(20ml+等渗盐水250ml,静脉滴注,1次/d,连续2周)。观察2组脑梗死患者治疗前、后神经功能评分、Barthel指数及活化部分凝血活酶时间(APTT)、血浆凝血酶原时间(PT)、组织型纤溶酶原激活物(tPA)、纤溶酶原激活物的抑制剂(PAI1),以及血栓烷B2(TXB2)、6酮前列腺素(6KetoPG)Flα的变化。结果ELHE组患者经过14d治疗,其神经功能缺失评分由9.4±4.0下降为3.3±1.2,Barthel指数由25.9±4.6升高为67.4±2.8,APTT、PT分别由(28.2±3.8)s、(12.2±3.5)s延长为(42.0±5.2)s、(19.5±2.1)s,血浆tPA含量及活性分别由(10.1±1.2)μg/L、(0.27±0.03)KIU/L升高为(15.3±2.1)μg/L、(0.57±0.12)KIU/L,血浆PAI1含量及活性由(47.8±4.6)μg/L和(0.77±0.12)KAU/L下降为(44.2±3.0)μg/L和(0.68±0.11)KAU/L,血栓烷B2由(228.4±48.9)ng/L降低为(152.7±44.4)ng/L,6KetoPGF1a由(21.9±6.3)ng/L升高为(33.8±6.4)ng/L,与对照组比较差异均有显著意义(P<0.05)。结论ELHE具有明显抗凝、促纤溶、抑制血小板聚集,改善血液循? Objective To investigate the efficacy and mechanism of extract liquor from hirudo and earthworm(ELHE) on treatment for patients with acute cerebral infarction. Methods 78 cases of patients with acute cerebral infarction were treated with conventional therapy. Among them, 40 cases group were added infusion of ELHE and the rest 38 patients were as control group.The changes of Neurological functional deficit scores, Barthel index (BI), APTT, PT, tPA, PAI-1, TXB2, and 6-Keto-PGF1a were observed between two groups before and after treatment. Results Compared with the control group after 14 days, the value of Neurological functional deficit scores were decreased from 9.4 ± 4.0 to 3.3 ± 1.2. The content and vitality of PAI-1 were reduced from(47.8 ± 4.6)μg/L and(0.77 ± 0.12)KAU/L to(44.2 ± 3.0)μg/L and(0.68 ± 0.11)KAU/L respectively, and the TXB2[from(228.4 ± 48.9)ng/L to(152.7 ± 44.4)ng/L]were remarkably reduced in ELHE group, while the amounts of Barthel index(from 25.9 ± 4.6 to 67.4 ± 2.8). The content and vitality of tPA were reduced from(10.1 ± 1.2)μg/L and(0.27 ± 0.03)KAU/L to(15.3 ± 2.1)μg/L and(0.57 ± 0.12)KAU/L respectively. The 6-Keto-PGF1a was elevated from(21.9 ± 6.3) ng/L to(33.8 ± 6.4)ng/L and the APTT(from 28.2 ± 3.8 to 42.0 ± 5.2), PT(from 12.2 ± 3.5 to 19.5 ± 2.1) were remarkabaly prolonged. There were significant difference between two groups(P < 0.05). Conclusion ELHE is effective and safe on protection and treatment for acute cerebral infarction, for it may accelerat fibrinolysis,anticoagulation, inhibit aggregation of platelets, and improve blood circulationin of the patients.
出处 《中国脑血管病杂志》 CAS 2005年第6期244-248,共5页 Chinese Journal of Cerebrovascular Diseases
基金 重庆市2003年度医学科学研究资助项目(032166)
  • 相关文献

参考文献11

二级参考文献60

  • 1徐琦,王克林,李涢,丁家欣,欧兴长.水蛭抗凝多肽基因在大肠杆菌中的表达[J].中国中医基础医学杂志,2000,6(5):22-27. 被引量:1
  • 2刘刚.新的抗凝药物─—水蛭肽的研究进展[J].国外医学(药学分册),1995,22(3):133-138. 被引量:20
  • 3李秀珍.开发中的抗栓剂——水蛭素及其12肽[J].军事医学科学院院刊,1996,20(1):73-75. 被引量:4
  • 4姜远英 龙星.血小板与缺血性脑血管疾病[J].中国心血管药理通讯,1992,12:4-4.
  • 5赵卫东 王子灿 等.大鼠脑再灌流综合症模型初探[J].中国神经精神疾病杂志,1987,13(4):193-195.
  • 6[1]Markwardt F. The development of hirudin as an antithrombotic drug. Thrombosis Research, 1994,74( 1 ): 1 ~ 23.
  • 7[2]Markwardt F. Hirudin and derivatives as anticoagulant agents. Thromb Heamost, 1991 ;66(1 ): 141 ~ 152.
  • 8[3]Vindigni V, Filippis VD, Zanotti G, et al. Probing the structure of hirudin from hirudinaria manillensis by limited proteolysis: isolation, characterization and thrombin-inhibitory properties of N-terminal fragments. Eur J Biochem,1994,226: 323 ~ 333.
  • 9[5]Nowak G, Markwardt F. Hirudin in disseminated intravascular coagulation.Haemostasis, 1991,21 (Supple 1 ): 142 ~ 148.
  • 10[6]Markwardt F, Kaiser B, Nowak G. Studies on antithrombotic effects of recombinant hirudin. Thromb Res, 1989,54(5) :377 ~ 388.

共引文献640

同被引文献317

引证文献23

二级引证文献1478

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部